Copeptin: A new biomarker that is specific for preeclampsia?

Hypertension

Volumn 64, Issue 6, 2014, Pages 1189-1191

  Cornelius, Denise C ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COPEPTIN; GLYCOPEPTIDE;

EARLY DIAGNOSIS; FEMALE; FETUS MORTALITY; HUMAN; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; NEWBORN MORBIDITY; NEWBORN MORTALITY; NONHUMAN; NOTE; PLACENTA; PLACENTAL DELIVERY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; TROPHOBLAST; VAGINAL DELIVERY; VASOPRESSIN RELEASE; BLOOD; BLOOD PRESSURE; PRE-ECLAMPSIA;

BLOOD PRESSURE; FEMALE; GLYCOPEPTIDES; HUMANS; PRE-ECLAMPSIA; PREGNANCY;

EID: 84922481213     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04255     Document Type: Note

References (10)

1. American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122-1131.
2. George EM, Granger JP. Recent insights into the pathophysiology of preeclampsia. Expert Rev Obstet Gynecol. 2010;5:557-566.
3. Yeung EH, Liu A, Mills JL, Zhang C, Männistö T, Lu Z, Tsai MY, Mendola P. Increased levels of copeptin before clinical diagnosis of preeclampsia. Hypertension. 2014;64:1362-1367.
4. Kar M. Role of biomarkers in early detection of preeclampsia. J Clin Diagn Res. 2014;8: BE01-BE04.
5. Santillan MK, Santillan DA, Scroggins SM, Min JY, Sandgren JA, Pearson NA, Leslie KK, Hunter SK, Zamba GK, Gibson-Corley KN, Grobe JL. Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model. Hypertension. 2014;64:852-859.
6. Dobsa L, Edozien KC. Copeptin and its potential role in diagnosis and prognosis of various diseases. Biochem Med (Zagreb). 2013;23:172-190.
7. Krege JH, Katz VL. A proposed relationship between vasopressinase altered vasopressin and preeclampsia. Med Hypotheses. 1990;31:283-287.
8. Zulfkaroglu E, Islimye M, Tonguc EA, Payasli A, Isman F, Var T, Danisman N. Circulating levels of copeptin, a novel biomarker in preeclampsia. J Obstet Gynaecol Res. 2011;37:1198-1202.
9. Foda AA, Abdel Aal IA. Maternal and neonatal copeptin levels at cesarean section and vaginal delivery. Eur J Obstet Gynecol Reprod Biol. 2012;165:215-218.
10. Wellmann S, Benzing J, Fleischlin S, Morgenthaler N, Fouzas S, Buhrer CA, Szinnai G, Burkhardt T, Lapaire O. Cardiovascular biomarkers in preeclampsia at triage [published online ahead of print May 17, 2014]. Fetal Diagn Ther. doi:10.1159/000361016. http://www.karger.com/Article/FullText/361016. Accessed August 4, 2014.